Subscribe free

Metabolic and Bariatric Surgery ·

Low-Dose Haloperidol Effectively Reduces Postoperative Nausea/Vomiting in Bariatric Surgery

In the pursuit of countering postoperative nausea and vomiting (PONV) among bariatric surgery patients, researchers integrated low-dose haloperidol into enhanced recovery protocols. Analyzing data from 475 patients, they found that those who received haloperidol had lower rates of PONV, required fewer additional antiemetics, and experienced significantly shorter hospital stays. This innovative approach not only eases patient discomfort but also enhances recovery, promoting safe discharge within 24 hours of bariatric surgery.

Journal Article by Lam P, Druar N (…) Shetty S et 2 al. in Surg Endosc

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →